{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-25-002464","form_type":"8-K","ticker":"ITGR","cik":"0001114483","company_name":"Integer Holdings Corp","filed_at":"2025-04-24T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.564320+00:00","generated_at":"2026-05-23T06:40:50.797837+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Integer Q1 sales +7% to $437M, adjusted EPS $1.31; raises 2025 adjusted EPS outlook","bullets":["Sales $437M (+7% YoY), organic +6%; Cardio & Vascular +17%, Cardiac Rhythm Management & Neuromodulation +2%.","Non-GAAP adjusted net income $46M (+19%), adjusted EPS $1.31 (up $0.17).","GAAP net loss $22M from debt conversion inducement expense on $1.0B 1.875% convertible notes due 2030.","Closed $1.0B convertible note offering; total debt $1.235B, leverage ratio 3.3x adjusted EBITDA.","2025 outlook: sales $1.846-1.880B (8-10% growth); adjusted EPS $6.15-6.51 (16-23% growth, raised)."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-25-002464","json":"https://secwatch.observer/filing/0001171843-25-002464.json","markdown":"https://secwatch.observer/filing/0001171843-25-002464.md","text":"https://secwatch.observer/filing/0001171843-25-002464.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1114483/000117184325002464/0001171843-25-002464-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1114483/000117184325002464/f8k_042325.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T06:40:50.797837+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}